XERS R&D to Revenue
Xeris Biopharma Holdings Inc · R&D to Revenue
XERS R&D to Revenue
Latest reported10.68%period ending
XERS FY R&D/Revenue (952.37% → 10.68%)
Latest values, visible window
High-resolution chart · PNG
XERS r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 10.6786% | |
| 12.5868% | |
| 13.6297% | |
| 19.0171% | |
| 50.736% | |
| 102.3783% | |
| 2,220.3527% | |
| 1,649.2495% | |
| 1,296.0154% | |
| 952.3721% |